Verrica Pharmaceuticals (VRCA) Short Interest Ratio & Short Volume → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free VRCA Stock Alerts $6.79 -0.19 (-2.72%) (As of 04/22/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Verrica Pharmaceuticals Short Interest DataCurrent Short Volume4,180,000 sharesPrevious Short Volume4,400,000 sharesChange Vs. Previous Month-5.00%Dollar Volume Sold Short$24.75 millionShort Interest Ratio / Days to Cover28.2Last Record DateMarch 31, 2024Outstanding Shares42,420,000 sharesFloat Size25,310,000 sharesShort Percent of Float16.52%Today's Trading Volume311,343 sharesAverage Trading Volume159,515 sharesToday's Volume Vs. Average195% Short Selling Verrica Pharmaceuticals ? Sign up to receive the latest short interest report for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVRCA Short Interest Over TimeVRCA Days to Cover Over TimeVRCA Percentage of Float Shorted Over Time Ad Crypto 101 MediaSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. Verrica Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/20244,180,000 shares $24.75 million -5.0%16.5%28.2 $5.92 3/15/20244,400,000 shares $21.12 million -0.7%17.4%22.4 $4.80 2/29/20244,430,000 shares $23.35 million +1.1%17.4%4.1 $5.27 2/15/20244,380,000 shares $24.35 million -1.1%17.3%4.1 $5.56 1/31/20244,430,000 shares $25.03 million -20.2%17.7%4.1 $5.65 1/15/20245,550,000 shares $31.75 million +5.3%22.1%5.1 $5.72 Get the Latest News and Ratings for VRCA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Verrica Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/31/20235,270,000 shares $38.58 million +44.4%21.0%4.9 $7.32 12/15/20233,650,000 shares $22.23 million -8.5%14.6%3.4 $6.09 11/30/20233,990,000 shares $14.68 million -6.3%15.9%25 $3.68 11/15/20234,260,000 shares $13.50 million +1.2%17.0%23.9 $3.17 10/31/20234,210,000 shares $15.49 million -2.3%16.7%21.7 $3.68 10/15/20234,310,000 shares $15.73 million -3.8%17.1%15.1 $3.65 9/30/20234,480,000 shares $17.40 million -9.3%17.8%11.8 $3.89 9/15/20234,940,000 shares $20.01 million +1.9%19.6%12.6 $4.05 8/31/20234,850,000 shares $22.07 million +7.5%19.3%11.5 $4.55 8/15/20234,510,000 shares $22.50 million +11.1%17.8%11.1 $4.99 7/31/20234,060,000 shares $23.71 million +34.4%16.0%10.7 $5.84 7/15/20233,020,000 shares $20.20 million +3.8%12.0%9.4 $6.69 6/30/20232,910,000 shares $16.79 million +33.5%11.5%13.3 $5.77 6/15/20232,180,000 shares $13.67 million +6.9%8.6%10.6 $6.27 5/31/20232,040,000 shares $11.57 million +14.6%8.1%13.4 $5.67 5/15/20231,780,000 shares $10.86 million +21.1%7.1%10.9 $6.10 4/30/20231,470,000 shares $9.07 million +55.7%5.9%7.6 $6.17 4/15/2023944,100 shares $5.85 million +60.7%3.8%4.9 $6.20 3/31/2023587,500 shares $3.82 million +94.8%2.4%3 $6.50 3/15/2023301,600 shares $2.01 million +24.8%1.2%1.7 $6.65 2/28/2023241,600 shares $1.87 million -7.5%1.0%1.4 $7.75 2/15/2023261,200 shares $1.97 million +12.1%1.1%1.6 $7.54 1/31/2023233,000 shares $1.08 million -50.7%1.0%1.7 $4.62 1/15/2023472,500 shares $2.29 million -18.4%2.0%4.2 $4.85 12/30/2022579,300 shares $1.59 million -7.9%2.4%5.9 $2.75 12/15/2022629,000 shares $1.98 million -4.2%2.6%8.1 $3.14 11/30/2022656,300 shares $2.13 million -5.7%2.7%6.6 $3.25 11/15/2022695,800 shares $1.59 million +6.0%2.9%7.1 $2.28 10/31/2022656,300 shares $1.63 million +7.0%2.7%6.5 $2.49 10/15/2022613,200 shares $1.67 million -1.9%2.6%5.7 $2.73 9/30/2022625,100 shares $1.83 million -19.6%2.6%4.5 $2.92 9/15/2022777,900 shares $2.96 million -9.8%3.2%2.4 $3.80 8/31/2022862,400 shares $3.38 million -10.1%3.7%2.6 $3.92 8/15/2022958,800 shares $3.75 million -8.7%4.1%1.8 $3.91SHOCKING Crypto Leak… (Ad)A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024. Claim your free seat by clicking here now. VRCA Short Interest - Frequently Asked Questions What is Verrica Pharmaceuticals' current short interest? Short interest is the volume of Verrica Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 4,180,000 shares of VRCA short. 16.52% of Verrica Pharmaceuticals' shares are currently sold short. Learn More on Verrica Pharmaceuticals' current short interest. What is a good short interest ratio for Verrica Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VRCA shares currently have a short interest ratio of 28.0. Learn More on Verrica Pharmaceuticals's short interest ratio. Which institutional investors are shorting Verrica Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Verrica Pharmaceuticals: Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Verrica Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 16.52% of Verrica Pharmaceuticals' floating shares are currently sold short. Is Verrica Pharmaceuticals' short interest increasing or decreasing? Verrica Pharmaceuticals saw a decline in short interest in the month of March. As of March 31st, there was short interest totaling 4,180,000 shares, a decline of 5.0% from the previous total of 4,400,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Verrica Pharmaceuticals' float size? Verrica Pharmaceuticals currently has issued a total of 42,420,000 shares. Some of Verrica Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Verrica Pharmaceuticals currently has a public float of 25,310,000 shares. How does Verrica Pharmaceuticals' short interest compare to its competitors? 16.52% of Verrica Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Verrica Pharmaceuticals: CorMedix Inc. (15.05%), Inozyme Pharma, Inc. (6.27%), Akebia Therapeutics, Inc. (6.40%), Erasca, Inc. (9.88%), Terns Pharmaceuticals, Inc. (10.92%), XOMA Co. (2.36%), RAPT Therapeutics, Inc. (8.56%), Aquestive Therapeutics, Inc. (3.10%), Kamada Ltd. (0.13%), Atea Pharmaceuticals, Inc. (2.26%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: TC Energy Co. ($4.49 billion), T-Mobile US, Inc. ($3.94 billion), General Motors ($3.34 billion), Charter Communications, Inc. ($3.32 billion), Occidental Petroleum Co. ($3.21 billion), Super Micro Computer, Inc. ($3.13 billion), Coinbase Global, Inc. ($3.08 billion), Moderna, Inc. ($2.28 billion), Tractor Supply ($2.24 billion), and Royal Caribbean Cruises Ltd. ($2.14 billion). View all of the most shorted stocks. What does it mean to sell short Verrica Pharmaceuticals stock? Short selling VRCA is an investing strategy that aims to generate trading profit from Verrica Pharmaceuticals as its price is falling. VRCA shares are trading down $0.19 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Verrica Pharmaceuticals? A short squeeze for Verrica Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VRCA, which in turn drives the price of the stock up even further. How often is Verrica Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VRCA, twice per month. The most recent reporting period available is March, 31 2024. More Short Interest Resources from MarketBeat Related Companies: CRMD Short Squeeze INZY Short Squeeze AKBA Short Squeeze ERAS Short Squeeze TERN Short Squeeze XOMA Short Squeeze RAPT Short Squeeze AQST Short Squeeze KMDA Short Squeeze AVIR Short Squeeze Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VRCA) was last updated on 4/23/2024 by MarketBeat.com Staff From Our PartnersThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThe A.I. story nobody is telling you (Read ASAP)TradeSmithHealthcare Takes A Big Step Forward With The Help Of AIThe Bull Reporttop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyDid You Get Your Free Bitcoin Yet?Crypto Swap Profits[Shocking] Elon Musk’s Plan To End BanksCrypto 101 MediaUrgent Alert: Biden's IRS Targeting Your Money – Act Fast to Protect It!American AlternativeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press